Zalinski, S <br/><br/>
[Does bevacizumab have a protective effect on hepatotoxicity induced by chemotherapy?].  [electronic resource] 

 -  Journal de chirurgie  Jan 2010 
 - S18-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1773-0422 
<br/><br/><label>Standard No.: </label>10.1016/S0021-7697(10)70004-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--toxicity<br/>Bevacizumab<br/>Chemotherapy, Adjuvant<br/>Colonic Neoplasms--pathology<br/>Hepatectomy<br/>Hepatic Veno-Occlusive Disease--chemically induced<br/>Humans<br/>Liver--drug effects<br/>Liver Neoplasms--drug therapy<br/>Neoadjuvant Therapy<br/>Organoplatinum Compounds--toxicity<br/>Oxaliplatin<br/>Protective Agents--therapeutic use<br/>Rectal Neoplasms--pathology<br/>Time Factors<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors